- Home
- FTHM vs IGC Comparison
FTHM vs IGC Comparison
Compare FTHM & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- IGC
- Stock Information
- Founded
- FTHM 2010
- IGC 2005
- Country
- FTHM United States
- IGC United States
- Employees
- FTHM N/A
- IGC N/A
- Industry
- FTHM Real Estate
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- FTHM Finance
- IGC Health Care
- Exchange
- FTHM Nasdaq
- IGC Nasdaq
- Market Cap
- FTHM 38.3M
- IGC 39.8M
- IPO Year
- FTHM 2020
- IGC N/A
- Fundamental
- Price
- FTHM $2.63
- IGC $0.41
- Analyst Decision
- FTHM
- IGC Strong Buy
- Analyst Count
- FTHM 0
- IGC 2
- Target Price
- FTHM N/A
- IGC $4.00
- AVG Volume (30 Days)
- FTHM 1.6M
- IGC 1.3M
- Earning Date
- FTHM 11-06-2025
- IGC 11-11-2025
- Dividend Yield
- FTHM N/A
- IGC N/A
- EPS Growth
- FTHM N/A
- IGC N/A
- EPS
- FTHM N/A
- IGC N/A
- Revenue
- FTHM $390,032,000.00
- IGC $1,327,000.00
- Revenue This Year
- FTHM $25.22
- IGC $15.26
- Revenue Next Year
- FTHM $16.19
- IGC $3.41
- P/E Ratio
- FTHM N/A
- IGC N/A
- Revenue Growth
- FTHM 19.16
- IGC 24.95
- 52 Week Low
- FTHM $0.65
- IGC $0.25
- 52 Week High
- FTHM $3.37
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- FTHM 64.22
- IGC 51.81
- Support Level
- FTHM $1.80
- IGC $0.38
- Resistance Level
- FTHM $3.09
- IGC $0.44
- Average True Range (ATR)
- FTHM 0.39
- IGC 0.03
- MACD
- FTHM 0.07
- IGC -0.00
- Stochastic Oscillator
- FTHM 55.05
- IGC 32.33
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.